Gene expression profiles in BCL11B-siRNA treated malignant T cells

Journal of Hematology and Oncology

Volumn 4, Issue , 2011, Pages

  Huang, Xin ^a,b   Shen, Qi ^a   Chen, Si ^a   Chen, Shaohua ^a   Yang, Lijian ^a   Weng, Jianyu ^b   Du, Xin ^b   Grabarczyk, Piotr ^c   Przybylski, Grzegorz K ^c,d   Schmidt, Christian A ^c   Li, Yangqiu ^a,e  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d INSTITUTE OF HUMAN GENETICS   (Poland)

^e JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LYMPHOMA 11B PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; ONCOPROTEIN; OSTEOPONTIN; PROTEIN BCL XL; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; BCL11B PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CREBBP PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; PROTEIN BCL X; REPRESSOR PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MOLT 4; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GENE; UPREGULATION; ADULT; BIOSYNTHESIS; CHILD; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

ADULT; BCL-X PROTEIN; CELL LINE, TUMOR; CHILD; CREB-BINDING PROTEIN; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 79955833178     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-4-23     Document Type: Article

References (22)

1. Molecular pathogenesis of T-cell leukaemia and lymphoma. I Aifantis E Raetz S Buonamici, Nat Rev Immunol 2008 8 380 390 10.1038/nri2304 18421304 (Pubitemid 351595220)
2. The clinical potential of microRNAs. BA Budhu JF Ji XW Wang, J Hematol Oncol 2010 3 37 10.1186/1756-8722-3-37 20925959
3. First-line treatment for chronic myeloid leukemia:dasatinib, nilotinib, or imatinib. GQ Wei S Rafiyath DL Liu, J Hematol Oncol 2010 3 47 10.1186/1756-8722-3-47 21108851
4. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. DK Graham DB Salzberg J Kurtzberg, Clin Cancer Res 2006 12 2662 2669 10.1158/1078-0432.CCR-05-2208 16675557
5. Therapeutic targeting of NOTCH1 signaling in T-ALL. T Palomero A Ferrando, Clin Lymphoma Myeloma 2009 9 Suppl 3 205 19778842
6. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. E Satterwhite T Sonoki TG Willis L Harder R Nowak EL Arriola H Liu HP Price S Gesk D Steinemann B Schlegelberger DG Oscier R Siebert PW Tucker MJ Dyer, Blood 2001 98 3413 3420 10.1182/blood.V98.12.3413 11719382
7. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. D Avram A Fields T Senawong A Topark-Ngarm M Leid, Biochem J 2002 368 555 563 10.1042/BJ20020496 12196208 (Pubitemid 35454533)
8. An Early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. L Li M Leid EV Rothenberg, Science 2010 329 89 93 10.1126/science.1188989 20595614
9. Bcl11b is required for differentiation and survival of T lymphocytes. Y Wakabayashi H Watanabe J Inoue N Takeda J Sakata N Takeda J Sakata Y Mishima J Hitomi T Yamamoto M Utsuyama O Niwa S Aizawa R Kominami, Nat Immunol 2003 4 533 539 10.1038/ni927 12717433 (Pubitemid 36701335)
10. BCL11B participates in the activation of interleukin-2 gene expression in CD4+ T lymphocytes. VB Cismasiu S Ghanta J Duque D Albu HM Chen R Kasturi, Blood 2006 108 2695 2702 10.1182/blood-2006-05-021790 16809611
11. Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity. P Liu P Li S Burke, Immunol Rev 2010 238 138 149 10.1111/j.1600-065X. 2010.00953.x 20969590
12. Disruption of the BCL11B gene through inv 14 q11.2q32.31 results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. GK Przybylski WA Dik J Wanzeck P Grabarczyk S Majunke JI Martin-Subero R Siebert G Dölken WD Ludwig B Verhaaf JJ van Dongen CA Schmidt AW Langerak, Leukemia 2005 19 201 208 10.1038/sj.leu.2403619 15668700 (Pubitemid 40220582)
13. Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells. A Karlsson A Nordigården JI Jönsson P Söderkvist, BMC Cancer 2007 7 195 10.1186/1471-2407-7-195 17941976
14. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14) (q35;q32). XY Su V Della-Valle I Andre-Schmutz C Lemercier I Radford-Weiss P Ballerini M Lessard M Lafage-Pochitaloff F Mugneret R Berger SP Romana OA Bernard V Penard-Lacronique, Blood 2006 108 4198 4201 10.1182/blood-2006-07-032953 16926283 (Pubitemid 44913293)
15. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. X Huang S Chen Q Shen LJ Yang B Li LY Zhong SX Geng X Du YQ Li, J Hematol Oncol 2010 3 44 10.1186/1756-8722-3-44 21080944
16. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). S Nagel M Kaufmann HG Drexler RA MacLeod, Cancer Res 2003 63 5329 5334 14500364 (Pubitemid 37139847)
17. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. A Oshiro H Tagawa K Ohshima K Karube N Uike Y Tashiro A Utsunomiya M Masuda N Takasu S Nakamura Y Morishima M Seto, Blood 2006 107 4500 4507 10.1182/blood-2005-09-3801 16484591 (Pubitemid 43801378)
18. BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes. VB Cismasiu S Ghanta J Duque DI Albu HM Chen, Blood 2006 108 2695 2702 10.1182/blood-2006-05-021790 16809611
19. + cells [abstract]. X Huang S Chen SH Chen LJ Yang Q Shen P Grabarczyk GK Przybylski CA Schmidt YQ Li, Blood 2010 116 1539 10.1182/blood-2009-06-230474 20472832
20. The Bcl-2 apoptotic switch in cancer development and therapy Bcl-2 apoptotic switch in cancer. JM Adams S Cory, Oncogene 2007 26 1324 1337 10.1038/sj.onc.1210220 17322918 (Pubitemid 46328466)
21. PI3-K/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL. L Caravatta S Sancilio V di Giacomo R Rana A Cataldi R Di Pietro, J Cell Physiol 2008 214 192 200 10.1002/jcp.21186 17579344 (Pubitemid 350220074)
22. Precursor T-cell acute lymphoblastic leukemia in adults: age-related immunophenotypic, cytogenetic, and molecular subsets. M Onciu R Lai F Vega C Bueso-Ramos LJ Medeiros, Am J Clin Pathol 2002 117 252 258 10.1309/08DJ-GPBH- H0VR-RC6F 11863221 (Pubitemid 34823666)